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Most solid tumors are aneuploid, having a chromosome
number that is not a multiple of the haploid number,
and many frequently mis-segregate whole chromosomes
in a phenomenon called chromosomal instability (CIN).
CIN positively correlates with poor patient prognosis,
indicating that reduced mitotic fidelity contributes to
cancer progression by increasing genetic diversity
among tumor cells. Here, we review the mechanisms
underlying CIN, which include defects in chromosome
cohesion, mitotic checkpoint function, centrosome copy
number, kinetochore–microtubule attachment dynamics,
and cell-cycle regulation. Understanding these mecha-
nisms provides insight into the cellular consequences of
CIN and reveals the possibility of exploiting CIN in cancer
therapy.
Introduction
Most solid tumors are aneuploid and many mis-segregate
chromosomes at very high rates in a phenomenon termed
chromosomal instability (CIN). Aneuploidy is a state in
which the number of chromosomes in a cell or organism
deviates from multiples of the haploid number of chromo-
somes. Chromosomal instability (CIN) is defined as a persis-
tently high rate of loss and gain of whole chromosomes.
For the purpose of this review, we adhere to the strict
definition of CIN as whole chromosome mis-segregation
and do not include structural rearrangements of chromo-
somes (translocations, deletions, inversions), although
these structural rearrangements may also be linked to
mis-segregation.
Aneuploidy was first associated with tumors in the late
19th century. In 1890, David von Hansemann examined tissue
sections from epithelial tumors and discovered cells that
were going through multipolar divisions as well as bipolar
yet asymmetric divisions of chromosomes [1]. Subsequently,
Theodor Boveri compared defects in sea urchin embryos that
had gone through multipolar divisions and proposed that
a ‘‘certain abnormal chromatin constitution’’, regardless of
how it originated, ‘‘would result in the origin of a malignant
tumor’’ [2]. The consequence of CIN is aneuploidy but the
line between aneuploidy and CIN was blurred in these early
studies because tools were not available to discriminate
between aneuploidy (a state that describes the cellular
karyotype) and CIN (increased rates of chromosome mis-
segregation). This distinction is important because aneu-
ploidy can arise in different ways; however, the fact that the
majority of aneuploid tumors have chromosome numbers
within the range of diploid cells — i.e. 40–60 chromosomes
(http://cgap.nci.nih.gov/Chromosomes/Mitelman; also see
[3]) — indicates that the accumulation of chromosomeDepartment of Biochemistry, Dartmouth Medical School, Hanover,
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single chromosomes through CIN may be the most common
pathway to aneuploidy. Because aneuploidy represents
a state of having an abnormal number of chromosomes and
CIN is a condition of an increased rate of chromosome mis-
segregation, the criteria needed to establish each condition
are different. Aneuploidy can be detected by any method
that quantifies chromosome numbers, including karyotype
analysis, fluorescence in situ hybridization, spectral karyo-
typing, or array-based comparative genomic hybridization
analyses. However, by themselves, these techniques are
not sufficient to yield quantitative measures of CIN. Detection
of CIN requires the determination of chromosome mis-segre-
gation rates [4], which can be achieved by coupling tools for
counting chromosomes with clonal cell assays that allow the
analysis of chromosomal variation in the resulting clonal pop-
ulation. In these assays, populations of cells derived from
chromosomally stable precursors will show little variation in
chromosome content (regardless of whether or not they are
aneuploid); in contrast, cells in a population derived from
a CIN precursor cell will show high levels of deviance in chro-
mosome content.
Using this single-cell colony assay, Vogelstein and
colleagues [5] ignited research into the mechanisms under-
lying CIN when they demonstrated two key properties of
colon cancer cell lines. First, they showed that colon cancer
cells with microsatellite instability (MIN) maintain a stable
chromosome content, but aneuploid colon carcinoma cells
exhibited deviations from the modal chromosome number
that ranged from 16% to 66%, indicating the presence of
CIN. High deviations in chromosome content in clonal pop-
ulations were subsequently reported in cells derived from
many other tumor types, including breast and lung [6,7],
indicating that CIN is a general property of aneuploid
cancer cells. Direct measurement of chromosome mis-
segregation rates in CIN cancer cell lines has recently
shown that these cells mis-segregate a chromosome, on
average, once every one to five cell divisions [8]. This may
represent the upper limit of tolerable chromosome changes
because massive chromosome mis-segregation caused by
checkpoint failure [9,10] or multipolar anaphase [11] is
lethal. Secondly, Vogelstein and colleagues [5] showed
that fusion of MIN and CIN cells resulted in hybrid cells
that retained the CIN phenotype, suggesting that the under-
lying mechanisms that cause CIN behave as dominant
traits.
Here, we discuss recent advances that illuminate the
underlying mechanisms causing CIN in human tumor cells.
These mechanisms reduce mitotic fidelity and include
defects in chromosome cohesion, the spindle assembly
checkpoint (SAC), centrosome copy number, kinetochore–
microtubule attachment dynamics, and cell-cycle regulation.
We further discuss how the knowledge gained by uncovering
these mechanisms unveils strategies to exploit CIN to
improve cancer therapy.
Chromosome Segregation in Mitosis
CIN represents the loss of chromosome segregation fidelity
in mitosis, so it is relevant to review the salient features of
mitosis that support faithful chromosome segregation.
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Figure 1. Chromosome segregation in mitosis.
(A) Chromosomes associate with spindle microtubules following nuclear envelope breakdown. The spindle assembly checkpoint is responsible
for preventing anaphase onset until all chromosomes form proper bi-oriented attachments to spindle microtubules. Destruction of cohesins
permits sister chromatid separation to define anaphase. To ensure faithful chromosome segregation all sister chromatids must segregate to
the same daughter cell. (B) Types of microtubule attachment. Correctly attached sister kinetochores orient toward opposite spindle poles
(amphitely). Erroneous attachments include situations where only one kinetochore is attached to a spindle pole (monotely), both sister kineto-
chores are attached to the same pole (syntely), or one sister kinetochore is attached to both poles (merotely).
Current Biology Vol 20 No 6
R286Mitosis is carefully choreographed to ensure that all sister
chromatids segregate to opposite daughter cells (Figure 1A).
Central to this choreography is sister chromatid cohesion,
which is established at the time of DNA replication by the
deposition of the cohesin complex. Proper chromosome
segregation requires that cohesion be maintained through
the G2 and M phases of the cell cycle and then abruptly dis-
rupted at the onset of anaphase. The precise timing of the
destruction of sister chromatid cohesion during mitosis is
determined by the coordinated activities of cyclin-depen-
dent kinases and the SAC. Chromosomes that are not
properly attached to spindle microtubules emit a signal to
maintain cyclin-dependent kinase activity, which inhibits
anaphase onset and preserves sister chromatid cohesion.
For example, mono-oriented chromosomes that lack attach-
ment at one kinetochore (monotely) emit the ‘wait anaphase’
signal, and a single unattached kinetochore is sufficient to
prevent anaphase onset [12,13]. Once all chromosomes
achieve proper bi-oriented attachments to spindle microtu-
bules, the SAC is satisfied and sister chromatid separation
is abruptly and synchronously induced on all chromosomes
by the cell-cycle machinery that proteolytically cleaves
the cohesin complex. Finally, in human cells each kineto-
chore attaches to an average of w20 microtubules and
all of these microtubules must orient toward the same
spindle pole to support faithful chromosome segregation.
The back-to-back geometry of sister kinetochores favors
chromosome bi-orientation on spindles [14–16], but the
stochastic nature of kinetochore–microtubule attachments
results in frequent misattachments in which single kineto-
chores simultaneously bind to microtubules emanating from
both spindle poles — known as merotely (for a schematicrepresentation of types of kinetochore–microtubule attach-
ment, seeFigure 1B). These merotelic attachments occur natu-
rally in early mitosis and are corrected prior to anaphase onset
to ensure faithful chromosome segregation [17]. It is note-
worthy thatmerotely isnot sensedby the SAC and, if left uncor-
rected, can cause sister chromatids to migrate to the same
spindle pole in anaphase leading to chromosome mis-segre-
gation [18].
Causes of Chromosomal Instability
Since the time that Vogelstein and colleagues [5] clearly es-
tablished the presence of CIN in aneuploid human tumor
cells, many research groups have pursued its underlying
cause. These efforts have revealed various mechanisms
through which tumor cells lose mitotic fidelity and proteins
involved in CIN are summarized in Table 1.
Cohesion Defects
Proteins that participate in chromosome cohesion were
identified through genetic strategies using assays that
measure the efficiency of transmission of minichromosomes
in budding yeast. Interestingly, somatic mutations in genes
whose products regulate sister chromatid cohesion,
including subunits of the cohesin complex, were recently
identified in human tumors in an expansive sequencing
strategy designed to identify mutations of the human homo-
logues of each gene known to induce CIN in budding yeast
[19]. No direct analysis was performed to test how these
mutations affect chromosome cohesion. Thus, it is unknown
whether cells carrying these mutations are disposed to
premature sister chromatid separation or to failure of
chromosome disjunction at anaphase onset, making it
Table 1. Proteins associated with CIN.
Protein Alteration Putative mechanism(s) Reference
APC Depletion, mutation Checkpoint defects, merotely [49,83,92–94,127,128]
Aurora A Overexpression Centrosome amplification, cytokinesis failure [58,59]
Aurora B Depletion, drug inhibition Checkpoint defects, merotely [55,69,70]
b-catenin Mutation Dysregulation of cell-cycle proteins, merotely [127]
BRCA1 Mutation Dysregulation of cell-cycle proteins, merotely [102]
BRCA2 Mutation Dysregulation of cell-cycle proteins [102]
Bub1 Heterozygous knockout,
hypomorph, mutation
Checkpoint defects [32,41]
Bub3 Heterozygous knockout Checkpoint defects [42,46]
BubR1 Knockout, mutation Checkpoint defect [30,31,43,45]
CAML Knockout Cytokinesis failure, merotely [129]
hCdc4/FBXW7 Depletion, knockout Dysregulation of cell-cycle proteins, merotely [104]
Cdc20 Mutation Checkpoint defects [44]
CENP-E Depletion, knockout Checkpoint defects, merotely [47,84,85,130]
CENP-F Depletion Checkpoint defects, merotely [86,106]
CENP-H Overexpression Cytokinesis failure, merotely [131]
CLASP Depletion Merotely [84,90]
Conductin/AXIN2 Overexpression Checkpoint defects, dysregulation of cell-cycle proteins [128]
Cyclin E Overexpression Centrosome amplification, dysregulation of cell-cycle
proteins, merotely
[104,105]
EB1 Depletion Merotely [94]
ECRG2 Depletion Centrosome amplification, checkpoint defects,
dysregulation of cell-cycle proteins
[132]
Eg5 Overexpression Cytokinesis failure [62]
FoxM1 Depletion, knockout Dysregulation of cell-cycle proteins [106]
Hec1–NDC80
complex
Antibody inhibition, mutation,
overexpression
Cytokinesis failure, merotely [73,87,133]
Hice-1 Depletion Cytokinesis failure, merotely [134]
Id1 Overexpression Cytokinesis failure [135]
Kif2a Depletion, with MCAK depletion Merotely [78]
Kif2b Depletion Merotely [67]
Kif4 Knockout Centrosome amplification, merotely [136]
Kruppel-like
factor 4
Knockout Centrosome amplification, chromosome breakage [111]
Mad1 Heterozygous knockout Checkpoint defects [40]
Mad2 Depletion, heterozygous knockout,
knockout, overexpression
Checkpoint defects, merotely [38,39,100,103,108]
MCAK Depletion Merotely [67,76,77]
MCT-1 Overexpression Merotely [137]
Mdm2 Overexpression Dysregulation of cell-cycle proteins [112]
MdmX Knockout Centrosome amplification, cytokinesis failure multipolar
anaphases
[113]
Mps1 Mutation Checkpoint defects, merotely [89]
p53 Knockout Dysregulation of cell-cycle proteins [101,108,137]
PRP4 Depletion Checkpoint defects, merotely [138]
Rad21/SCC1
(cohesin subunit)
Mutation Cohesion defects [19]
Rae1 Heterozygous knockout Checkpoint defects [46]
RanBP1 Depletion Merotely [114]
Rb Depletion Centrosome amplification, dysregulation of mitosis
proteins causing overactivation of checkpoint
[103]
REST Mutation Dysregulation of mitosis proteins causing checkpoint
defects
[109]
SCC3
(cohesin subunit)
Mutation Cohesion defects [19]
Securin Knockout, overexpression Cohesion defects [22,24]
Separase Knockout, overexpression Cohesion defects, cytokinesis failure [21,23]
SMC1
(cohesin subunit)
Depletion, mutation Cohesion defects, cytokinesis failure [19]
SMC3
(cohesin subunit)
Mutation Cohesion defects [19]
Sgo1 Depletion Cohesion defects, cytokinesis failure [20]
Sgo2/tripin Depletion Cohesion defects, merotely [88]
TMAP/CKAP2 Depletion Merotely [139]
Topoisomerase II Drug inhibition Catenation, merotely [140]
Von Hippel Lindau Depletion Checkpoint defects [110]
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R287impossible to evaluate their role in CIN. Nevertheless, the
acute depletion of cohesins or of the cohesion regulators
Sgo1 and separase (the enzyme that cleaves cohesins toinitiate anaphase) using RNA interference elevates the
numbers of tetraploid cells [19–21]. Tetraploid cells also
arise in cells overexpressing separase or a non-degradable
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prior to anaphase) [20,22–24], indicating that disturbances
of cohesion tend to cause global effects on chromosome
segregation rather than elevating the incidence of single
chromosome mis-segregation. In addition, large-scale
sequencing of tumor genomes reveals that cohesin genes
are rarely mutated [25–29]. Nevertheless, the possibility
that dominant mutations in cohesin subunits increase chro-
mosome mis-segregation by preventing timely chromosome
separation remains open, and this scenario would fit with
the dominant behavior of CIN in cell fusion experiments. An
alternative view worth exploring is whether mutations in
cohesin subunits impair the orderly packing of centromeric
chromatin leading to disruption of the typical back-to-back
orientation of sister kinetochores. Beyond these specific
mutations, there are other hints that disruption of cohesion
may contribute to CIN. For example, high levels of separase
are seen in breast cancer tumor samples compared with
normal tissue controls [23]. Excessive separase could
induce premature sister chromatid disjunction leading to
chromosome mis-segregation. Yet the interpretation of
altered mRNA levels in tumors is unclear because of differ-
ences in mitotic indices between tumor and normal tissue.
This discrepancy is widespread and applies to many other
areas comparing normal and tumor tissues.
SAC Defects
Molecular components of the SAC were identified in budding
yeast using genetic strategies that led to the isolation of
mutant strains that failed to arrest cell-cycle progression in
the presence of spindle poisons. Homologues of most of
these yeast genes have been identified in other eukaryotic
species, indicating that the molecular underpinnings of this
checkpoint are highly conserved. These components
generate the checkpoint signal emanating from kinetochores
to prevent anaphase onset until all chromosomes form
proper bipolar attachments to spindle microtubules. Impair-
ment of the SAC permits precocious anaphase onset and
significantly increases the likelihood for chromosome mis-
segregation, meaning that mutations in SAC genes can
cause CIN. Support for this view comes from mosaic varie-
gated aneuploidy, an extremely rare disease linked to muta-
tions in the gene encoding the SAC protein Bub1-related
kinase (BubR1). Mosaic variegated aneuploidy causes
growth retardation, microcephaly, childhood cancer, and
often results in death at a young age [30,31]. Premature sister
chromatid separation is often seen in >50% of lymphocytes
from patients with mosaic variegated aneuploidy, and in
many tissues more than 25% of cells are aneuploid; presum-
ably, this high level of aneuploidy contributes to the elevation
of cancer in these patients [30,31]. In addition to the clinical
evidence, experimental data show that aneuploid tumor cells
with CIN fail to maintain mitotic arrest when exposed to
spindle poisons for extended times, resulting in a lower
mitotic index between CIN cells and stable diploid cells
[32]. This indicates a failure of the SAC to maintain arrest
compared with what is seen in normal cells. Indeed, it was
shown that some tumor cell lines have decreased levels of
the SAC protein Mad2 [33–35], and mutations have been
identified in a few colon cancer cell lines in the gene encod-
ing Bub1 [32], another SAC protein, as well as in the Mad2
gene in a breast cancer cell line and in multiple gastric cancer
tumor cell lines [36,37]. Finally, experimentally induced dele-
tion of one copy of the Mad2 gene in otherwise stable diploidHCT116 colon carcinoma cells increased chromosome mis-
segregation [38].
These initial reports linking CIN to defective SAC activity
spawned a series of experiments using mouse models to
test whether aneuploidy and CIN contribute to tumorigen-
esis. Because complete SAC ablation is lethal to cultured
cells [9,10], it is no surprise that homozygous deletion of
many SAC genes, including Mad2, Mad1, Bub1, BubR1,
and Bub3, are embryonic lethal in mice [39–43]. However,
mice heterozygous for mutations in specific SAC genes are
viable. These animals develop normally but display elevated
chromosome mis-segregation rates compared with control
animals, consistent with attenuated checkpoint activity.
Many of these heterozygous animals have an increased
tumor incidence late in life, although this is highly dependent
on the gene that was targeted and there is also variability in
the tissue affected [38,40,41,44]. For example, mice hetero-
zygous for mutations in Mad2 develop spontaneous lung
tumors after 18 months [38], and mice with hypomorphic
Bub1 alleles display an increase in hepatocellular carci-
nomas, lung adenocarcinomas, sarcomas, and lymphomas
after 19 months [41]. In contrast, mice heterozygous for
Bub1, BubR1, Bub3, or Rae1 do not form spontaneous
tumors [41,45,46], despite having similar levels of aneuploidy
in spleen cells and mouse embryonic fibroblasts when
compared with other checkpoint-deficient mice that do get
tumors. The fact that tumors are seen in many of these trans-
genic mouse models suggests that aneuploidy or CIN
promotes tumorigenesis, although recent work shows that
loss of mitotic fidelity can also suppress tumorigenesis de-
pending upon the tissue context [47]. Assuming these animal
models have an elevated frequency of chromosome mis-
segregation throughout life, the delay between tumor
appearance and the onset of aneuploidy and CIN (beginning
at embryogenesis) — often 18 months or more — suggests
that chromosome mis-segregation promotes tumorigenesis
in cells that have acquired additional mutations. Chromo-
some loss is a known mechanism for revealing recessive
mutations in tumor suppressor genes in human tumors
[48]. It is important to emphasize that these animal studies
fail to distinguish between the distinct contributions of aneu-
ploidy (a state of improper numbers of chromosomes) and
CIN (a high rate of chromosome mis-segregation) in the
promotion or suppression of tumorigenesis because both
CIN and aneuploidy are induced in these models.
Despite the aforementioned evidence, the role of check-
point impairment in the widespread occurrence of CIN is still
a matter of debate. It is becoming increasingly accepted that
most cancer cells with CIN have a functional SAC. For
example, no difference was reported between the abilities
of diploid cells and cancer cells with CIN to arrest in mitosis
in the presence of spindle poisons [49]. Moreover, direct
observation of multiple CIN cell lines undergoing mitosis re-
vealed that no cells entered anaphase prior to alignment of
all chromosomes [8,50]. Collectively, these results provide
robust evidence that the checkpoint in many CIN cell lines
is functioning to prevent anaphase onset until kinetochores
on all chromosomes attach to spindle microtubules. It was
recently shown that cells with CIN have a higher rate of death
during prolonged arrest in mitosis, providing a reasonable
explanation for the previously observed decrease in mitotic
index for CIN cell lines [51], although the differences in
response to microtubule-targeted drugs between cells with
CIN and MIN may not be universal [50,52]. Furthermore,
Figure 2. Lagging chromosomes in human melanoma.
Anaphase cells in a hematoxylin-and-eosin-stained section of a human
melanoma show lagging chromosomes (arrow) consistent with mitotic
defects observed in cultured tumor cell lines. Image provided by Vin-
cent Memoli (Department of Pathology, Dartmouth-Hitchcock Medical
Center and Norris Cotton Cancer Center).
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mosome mis-segregation [9,10], and the purported loss of
function of the SAC in CIN cells does not fit with the dominant
behavior of CIN in cell fusion studies [5]. Finally, no mutations
in checkpoint genes were found when DNA was sequenced
from over 100 cancer cell lines [19] or from hundreds of
tumors from multiple tissues [25–29]. Taken together, it
appears that mutations that erode SAC function are quite
rare in human CIN tumors. Whereas some tumor cells may
have a reduced capacity to maintain mitosis for extended
periods when challenged with spindle poisons, the bulk of
the evidence indicates that the SAC in most cancer cells
with CIN is functional and prevents precocious anaphase
under normal growth conditions.
Supernumerary Centrosomes
Direct analysis of human tumor cell lines with CIN shows that
the most common mitotic defect is lagging chromosomes in
anaphase [8]. Lagging chromosomes can also be observed
during anaphase in human tumors, indicating that these
errors are not unique to cultured cell lines (Figure 2). Exami-
nation of CIN cell lines using fixed cell analyses shows that
this mitotic defect represents single chromatids that fail to
segregate because the kinetochore is attached to spindle
microtubules that are oriented toward opposite spindle
poles in a merotelic conformation [8]. Merotely is only
possible in eukaryotic cells where single kinetochores bind
multiple microtubules and is usually disfavored by the
back-to-back geometry of sister kinetochores [14–16].
However, many kinetochores become merotelic in early
phases of mitosis due to the stochastic interaction between
kinetochores and spindle microtubules [17]. The microtubule
occupancy of merotelic kinetochores is equivalent to that of
kinetochores on properly bioriented chromosomes, so the
SAC is appropriately satisfied in the presence of these erro-
neous attachments [18]. Thus, it is critical that merotelic
kinetochores be corrected prior to anaphase onset to ensure
error-free chromosome segregation. Indeed, the incidence
of lagging chromosomes during anaphase increases in cells
with attenuated SAC activity, suggesting that those cells did
not have sufficient time to correct all merotelic attachments
prior to anaphase onset.
The prevalence of merotelic attachments is determined by
two rates: the rate of their formation and the rate of their
correction (Figure 3). Treatments that disrupt spindle geom-
etry significantly increase the formation of merotelic attach-
ments. For example, mitotic cells recovering from microtu-
bule-depolymerizing agents, such as nocodazole, proceed
through a multipolar spindle intermediate that induces high
rates of merotely and subsequent lagging chromosomes
[17,53,54]. Recovery from inhibitors of the kinesin-5 motor
protein Eg5 proceed through monopolar spindle intermedi-
ates and similarly have elevated levels of merotely and
lagging chromosomes at anaphase [55]. These drug
recovery approaches have been used to show that CIN can
be induced in otherwise stable cells by transiently disrupting
spindle geometry to increase the prevalence of merotely [8].
Cells with more than two centrosomes often coalesce the
extra centrosomes during mitosis to ensure that anaphase
occurs with a bipolar spindle [56]. It was recently shown
that extra centrosomes induce transient multipolar spindles
prior to coalescence of centrosomes into bipolar spindles,
and this event significantly increases the incidence of mer-
otely and elevates chromosome mis-segregation rates(Figure 3) [11,57]. This provides a straightforward explana-
tion for the long-standing correlation between extra centro-
somes and CIN in many tumor cells. More direct analysis
showed that induction of extra centrosomes in otherwise
chromosomally stable cells was sufficient to elevate lagging
chromosomes and induce chromosome mis-segregation
through excessive merotely induced by transient multipolar
spindles [11].
Extra centrosomes are produced either by deregulation of
the centrosome duplication cycle or as a by-product of cells
that become tetraploid. For example, centrosome amplifica-
tion has been shown to arise through overexpression of
Aurora A kinase [58,59] or viral infection [60]. Tetraploidy
can arise through viral-induced cell fusion [61], overexpres-
sion of Eg5 [62], or cytokinesis failure. Tetraploidy is a likely
precursor to tumor cells with near-tetraploid karyotypes and
has long been hypothesized to be a precursor of aneuploidy
because it is found prior to gross aneuploidy in early tumors
in Barrett’s esophagus and cervical cancer [63,64], and p53-
deficient tetraploid cells (but not p53-deficient diploid cells)
form tumors when injected into immune-compromised
mice [65]. Since mechanisms generating tetraploidy also
result in the presence of extra centrosomes, it is likely that
tetraploid cells are highly prone to have CIN. Taken together,
it appears that a common route to CIN can be through the
acquisition of extra centrosomes that significantly increase
the rate of formation of merotelic kinetochore attachments.
Presumably, the levels of merotely in these situations exceed
the capacity of the correction machinery to efficiently repair
them prior to anaphase onset.
Defects in Kinetochore–Microtubule Attachment
Dynamics
Microtubule attachment to kinetochores is reversible [66]
and the rate-limiting step in the correction of erroneous
kinetochore–microtubule attachments is the release of
microtubules from kinetochores [67]. The repeated associa-
tion and dissociation of individual microtubules from
kinetochores generates a dynamic kinetochore–microtubule
attachment that is necessary to promote error correction.
Normal diploid cells
Metaphase Anaphase
Cancer cells with CIN
Cells with extra centrosomes
Prometaphase
Lagging chromosome
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Figure 3. Formation and correction of merotelic kinetochore–microtubule attachments.
Merotely arises in early mitosis in normal cells, but is efficiently corrected (lightning bolts) to establish proper bi-orientation needed for error-free
chromosome segregation. Kinetochore–microtubule attachments in cancer cells with CIN are hyperstable, which reduces their intrinsic ability to
correct merotelic attachments. Spindle assembly in cells with extra centrosomes progresses through transient multipolar intermediates that
greatly increase the formation rate of merotelic attachments.
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chore ensures that chromosomes remain tethered to spindle
microtubules despite the continuous association/dissocia-
tion of individual microtubules. The dynamic turnover of
kinetochore–microtubule attachments has been measured
in various cell lines and is rapid in early mitosis (t1/2 =
2–3 minutes), slows as chromosomes align in metaphase
(t1/2 = 5–7 minutes), and slows further when cells enter
anaphase (t1/2 = 50 minutes) [67–69]. Thus, kinetochore–
microtubule attachment stability is regulated in a very narrow
range during different phases of mitosis, particularly at the
crucial stage between prometaphase and metaphase when
many erroneous attachments need to be corrected.
The molecular machinery involved in regulating kineto-
chore–microtubule attachment dynamics is beginning to
emerge. The centromere-localized Aurora B kinase is a
central controller of this process because inhibition of this
kinase renders the attachment of microtubules to kineto-
chores virtually irreversible [69,70]. Among the many centro-
mere and/or kinetochore targets of Aurora B kinase are the
Ndc80 complex, which is required for kinetochore–microtu-
bule attachment, and members of the kinesin-13 family of
microtubule-depolymerizing enzymes [67,71–73]. Loss of
function of the Ndc80 complex virtually eliminates stable
kinetochore–microtubule attachments, indicating that it
plays a key role in kinetochore–microtubule attachment
[74,75]. Conversely, loss of function of kinesin-13 proteins,
such as Kif2b and MCAK, results in higher rates of lagging
chromosomes, showing that they are instrumental in correc-
tion of erroneous kinetochore-microtubule attachments
[67,76–78]. Two of the three members of the kinesin-13
subfamily have overlapping responsibilities in this role in
human cells. Kif2b localizes to outer kinetochores and
destabilizes kinetochore–microtubule attachments inprometaphase [67,79]. This role appears to be critical to
correct the numerous erroneous kinetochore–microtubule
attachments that arise in prometaphase. Conversely,
MCAK localizes to centromeres and destabilizes kineto-
chore–microtubule attachments predominantly during meta-
phase [67,79], which appears to be essential to prevent the
formation of new merotelic attachments once chromosomes
have aligned on the spindle.
Evidence indicates that tension generated between sister
kinetochores regulates these correction mechanisms.
Aurora B kinase generates a phosphorylation gradient
emanating from the inner centromere [80,81] that influences
both the localization and activities of MCAK and Kif2b. With
few microtubule attachments in early mitosis, tension
between sister kinetochores is low and the phosphorylation
gradient extends to suppress MCAK activity and recruit
Kif2b to outer kinetochores. As chromosomes biorient,
tension builds between sister kinetochores and shifts the
position of target proteins from the boundaries of the phos-
phorylation gradient. This results in the release of Kif2b from
kinetochores and the activation of MCAK [67,71,82]. Accord-
ingly, disruption of the spatial boundaries of this phosphory-
lation gradient by repositioning Aurora B kinase close to the
kinetochore strongly destabilizes kinetochore–microtubule
attachments and prevents the onset of anaphase [81]. These
(and probably other) molecular changes are reflected in the
stabilization of kinetochore–microtubule attachments as
cells progress from prometaphase to metaphase and,
presumably, into anaphase. A remaining question is whether
indiscriminate changes in kinetochore–microtubule attach-
ment dynamics that occur during these mitotic transitions
are sufficient for efficient error correction [67] or whether
erroneous kinetochore attachments are uniquely recognized
by cellular machinery to promote their correction [55].
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tubule dynamics as cells progress through mitosis makes it
a sensitive target for the disruption of mitotic fidelity. Insults
that destabilize kinetochore–microtubule attachments, such
as the repositioning of Aurora B kinase described previously
[81], mean that satisfaction of the checkpoint and progres-
sion into anaphase are impossible because kinetochores
never achieve sufficient microtubule occupancy. In contrast,
insults that stabilize kinetochore–microtubule attachments
would prevent efficient correction of attachment errors
(mediated by the release of inappropriately attached micro-
tubules) and promote chromosome mis-segregation.
Accordingly, it was recently shown that kinetochore–micro-
tubule attachments are more stable in tumor cells with CIN
than in a chromosomally stable diploid cell line [83]. CIN
cancer cells displayed hyperstable kinetochore–microtubule
attachments in prometaphase, or metaphase, or both and
this was not dependent on the numbers of centrosomes
present, indicating that the tested cell lines have an inherent
defect in correcting erroneous kinetochore–microtubule
attachments. Moreover, overexpression of the kinesin-13
microtubule depolymerases MCAK and Kif2b reduced kinet-
ochore–microtubule attachment stability and restored faith-
ful chromosome segregation to cancer cells that otherwise
showed CIN [67]. This is the only example in which chromo-
some segregation fidelity has been restored to cancer cells
that have CIN and provides compelling evidence that exces-
sively stable kinetochore–microtubule attachments are the
root cause of CIN in many cancer cells.
The list of centromere/kinetochore proteins whose pertur-
bation reduces segregation fidelity due to elevation of kinet-
ochore–microtubule mal-attachment is growing rapidly.
Perturbation of many of these (Kif2b [67], MCAK [76,77],
CENP-E [84,85], CENP-F [86], the Ndc80 complex [73,87],
Aurora B [55,69,70], Sgo2 [88], Mps1 [89], CLASPs [84,90],
Ndel1 [91], and APC [83,92–94]) has been shown to elevate
the frequency of merotely and lagging chromosomes in
anaphase. This infers that kinetochore–microtubule attach-
ments become excessively stable upon perturbation of
these proteins and this in turn reduces the efficiency of
correction of erroneous kinetochore–microtubule attach-
ments leading to CIN. This inference has been verified in
several instances. As mentioned previously, perturbation of
either Aurora B or MCAK activity stabilizes kinetochore–
microtubule attachments and increases the numbers of
lagging chromosomes in anaphase [69,70,95]. Furthermore,
APC is frequently mutated in colon cancer and cells with
mutations in APC show high rates of lagging chromosomes
in anaphase [92–94]. It was recently shown that depletion
of APC increased kinetochore–microtubule stability and
induced lagging chromosomes in otherwise stable diploid
cells, and this defect was rescued by concomitant overex-
pression of proteins that promoted kinetochore–microtubule
dynamics [83]. Moreover, depletion of CENP-E stabilizes
kinetochore–microtubule attachments [84] and we have
observed a consequent increase in lagging chromosomes
in anaphase in human HCT116 cells lacking CENP-E (S.L.T.
and D.A.C., unpublished observations).
Despite this cellular evidence, the only gene from the
above list for which mutations have been directly observed
at high frequencies in tumors is APC and mutations in others
are quite rare (Aurora B [28] and CLASPs [26]) or not detected
at all [25–29]. However, loss-of-function mutations would not
be expected based on the dominant behavior of CIN in cellfusion experiments, and there is evidence for a dominant
effect of APC mutations [5,96,97]. Thus, a more likely
scenario is that imbalances in the levels of these proteins
act dominantly to stabilize kinetochore–microtubule attach-
ments beyond a certain threshold, leading to deficiencies
in error correction and chromosome mis-segregation. These
imbalances in protein levels could be generated by an initial
chromosome mis-segregation event or by epigenetic mech-
anisms. The idea that protein imbalances induce CIN has
been proposed previously based on the consistency with
which chemically induced transformation associates with
aneuploidy and CIN in cultured hamster cells [98,99]. This
view is further supported by experiments showing that over-
expression of Hec1, a component of the Ndc80 complex,
causes high levels of lagging chromosomes and chromatin
bridges in mouse cells and can induce tumors [87]. Mad2
overexpression also increases the frequency of lagging
chromosomes in anaphase and can increase the rate of
spontaneous tumor formation [100]. Moreover, recent data
shows substantial variability in the levels of mitotic proteins
that participate in kinetochore–microtubule dynamics in
tumor cells compared with stable diploid cells [83]. Accord-
ingly, when diploid cells are rendered tolerant for a non-
diploid genome through loss of p53, they display CIN
following initial chromosome mis-segregation events [101],
showing that perturbation of chromosomal content (and
hence a plethora of transcript levels) may have a cyclical
effect in driving a perpetual state of CIN. This view is counter
to initial data showing that trisomy 3 was insufficient to
induce CIN [5], but this particular trisomy may not imbalance
kinetochore–microtubule attachment dynamics and other
compensatory changes may have arisen. It remains
unknown whether kinetochore–microtubule attachments
are indeed stabilized by protein imbalances that arise from
spontaneous chromosome mis-segregation. Nevertheless,
a clear picture has emerged that can explain why lagging
chromosomes are the most commonly observed cause of
CIN in cancer cells: the relatively narrow acceptable range
of kinetochore–microtubule dynamics needed for error-free
mitosis, which is coupled to the large number of available
protein targets that could disrupt these dynamics, makes
CIN-causing alterations highly likely.
Defects in Cell-Cycle Regulation
In addition to proteins that function directly in the process of
chromosome segregation during mitosis, there are
numerous cell-cycle regulators that have been associated
with CIN (including BRCA1 and BRCA2 [102], Rb [103],
hCDC4 [104], cyclin E [105], FoxM1 [106,107], p53 [101,108],
REST [109], Von Hippel Lindau [110], Kruppel-like factor
[111], Mdm2 [112], MdmX [113], and RanBP1 [114]). The
precise role that many of these cell-cycle regulators play in
inducing CIN is not currently clear, but three general path-
ways are possible. First, these well-known cell-cycle regula-
tors may directly participate in supporting chromosome
segregation fidelity during mitosis in roles that had not been
previously recognized. Second, deregulation of cell-cycle
events outside of M phase (e.g. centrosome duplication
during S phase) may indirectly promote chromosome mis-
segregation during the ensuing mitosis. Finally, disruption
of cell-cycle checkpoints may permit cells that have mis-
segregated chromosomes to continue cell-cycle progres-
sion. In the following paragraphs we summarize data high-
lighting how a few of these cell-cycle regulatory proteins
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ular examples simply to emphasize the general principles for
how deregulation of the cell cycle can lead to CIN.
hCDC4 (also called Fbw7) is an E3 ubiquitin ligase that
targets cyclin E for degradation and thereby regulates the
G1–S cell cycle transition [104]. hCDC4 is mutated in many
cancers, includingw12% of colorectal cancers [104]. Homo-
zygous knockout of hCDC4 in otherwise chromosomally
stable HCT116 cells generates CIN, which can be amelio-
rated by depletion of cyclin E, indicating that mitotic defects
are created through exaggerated cyclin E–Cdk activity [104].
Cyclin E regulates centrosome duplication during the cell
cycle [115,116] and extra centrosomes promote CIN by
increasing the frequency of merotelic kinetochore attach-
ments, providing a mechanistic link between cyclin E levels
and CIN. However, the role of hCDC4 mutations in CIN is still
under debate [117], and mutations in hCDC4 do not seem to
occur more frequently in CIN tumors compared with chromo-
somally stable, MIN tumors [118].
Cell-cycle regulators also control the levels of components
of the SAC. For example, repressor-element-1-silencing
transcription factor (REST) is a transcriptional repressor
that must be degraded to permit transcription of the Mad2
gene [109]. Timely destruction of REST in the G2 phase of
the cell cycle is mediated by the E3 ligase b-TrCP. Expres-
sion of a REST mutant that does not interact with b-TrCP
results in low levels of Mad2 that lead to chromosome segre-
gation defects in mitosis akin to those observed in Mad2
heterozygotes [109]. Another example is the Rb tumor
suppressor protein. Rb regulates the transcriptional acti-
vator E2F [103]. One target of E2F transcriptional activation
is the Mad2 gene and loss of Rb results in overexpression
of Mad2, which has been shown to induce CIN [100,103].
Finally, FoxM1 is a cell-cycle regulator that has been asso-
ciated with CIN: 80% of mouse embryo fibroblasts lacking
FoxM1 are aneuploid compared with 20% of wild-type
controls [106]. Human U2OS cells depleted of FoxM1 have
multiple problems because they enter anaphase with
unaligned chromosomes, have high numbers of lagging
chromosomes, and often fail in cytokinesis [106]. Addition-
ally, FoxM1 overexpression has been reported in tumor cell
lines with CIN [107]. FoxM1 activates the transcription of
many mitotic proteins, including cyclin B, CENP-F, and
Plk-1 [106]. Thus, loss of FoxM1 may cause CIN by altering
the expression of one or more of these mitotic proteins or
by creating imbalances in mitotic proteins that disrupt
normal mitotic progression.
CIN as a Target for Cancer Therapy
CIN in tumors is associated with poor patient prognosis
[119–121] and contributes to tumor evolution through the
acquisition of metastatic potential and resistance to some
chemotherapeutic agents [52,122,123]. Through persistent
chromosome shuffling, tumor cells with CIN continuously
sample the genetic landscape with an almost limitless
number of combinations, based on evidence in vertebrate
cells that all chromosomes have an equal probability for
mis-segregation [124]. Whereas some chromosome combi-
nations may provide no selective advantage or a disadvan-
tage, others could provide growth advantages to cells in
the tumor microenvironment, particularly under the selective
pressure applied by chemotherapy. In this context, CIN
provides tumor cells with adaptability that permits them to
acquire new phenotypes, such as drug resistance. It maytherefore prove therapeutically beneficial to suppress CIN
and thereby eliminate tumor cell adaptability. Suppression
of CIN through the overexpression of MCAK and Kif2b
provides proof of principle that CIN can be suppressed
in tumor cells [67], and this avenue could be exploited
to prevent acquisition of resistance to conventional
chemotherapy.
An alternative strategy would be to intentionally promote
chromosome mis-segregation. Unlike aneuploid tumor cells,
diploid cells fail to propagate efficiently following chromo-
some mis-segregation [8]. One molecular pathway that limits
the growth of diploid cells following chromosome mis-
segregation involves p53 [101] and serves to highlight that
aneuploid tumor cells have acquired tolerance for non-
diploid genomes. This tolerance permits them to propagate
efficiently as they constantly mis-segregate single chromo-
somes at high rates in association with CIN. However, toler-
ance is limited because aneuploid tumor cells die when
large numbers of chromosomes mis-segregate in a single
cell division cycle. Such massive chromosome changes
arise when the SAC is abrogated [9,10] or when cells prog-
ress through a multipolar anaphase induced by extra centro-
somes [11]. Thus, strategies that elevate chromosome
mis-segregation beyond tolerable levels could be therapeu-
tically beneficial. An obvious approach for this would be
to abrogate the SAC in tumor cells, and a variation on
this theme includes partial checkpoint inhibition coupled
with treatments that disrupt proper chromosome segrega-
tion [125]. Another approach would involve induction of
lethal multipolar anaphase in tumor cells carrying extra
centrosomes by targeting proteins involved in centrosome
clustering (e.g. the kinesin-14 motor HSET). Proof of prin-
ciple for this strategy comes from recent work showing
that multipolar anaphase is induced by depletion of HSET
[11] and that Cdk2 inhibitors suppress the growth of lung
tumors that overexpress cyclin E by inducing multipolar
anaphases [126].
Conclusions
In summary, investigations into the basic mechanisms of
chromosome segregation have revealed many defects that
increase chromosome mis-segregation rates and cause
CIN. These insights provide the tools to directly manipulate
the frequency of chromosome mis-segregation in tumor
cells to induce or suppress CIN. Importantly, these tools
will prove invaluable in determining how CIN, independently
of aneuploidy, contributes to tumorigenesis and could be
used therapeutically to limit tumor growth.
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